| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Revenue | $6.32B | -2.9% |
| Cost of Revenue | $5.38B | -3.2% |
| Gross Profit | $933.2M | -1.1% |
| R&D Expense | $163.0M | -8.2% |
| SG&A Expense | $331.8M | +12.3% |
| Operating Income | $438.5M | -6.8% |
| Pre-tax Income | $431.0M | -2.9% |
| Income Tax | $75.5M | -7.6% |
| Net Income | $354.0M |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $1.13B | +1.2% |
| Short-term Investments | $513.0M | +8.0% |
| Accounts Receivable | $1.06B | -8.2% |
| Inventory | $310.9M | -20.9% |
| Current Assets | $3.07B | -3.8% |
| Total Assets | $6.94B | +2.6% |
| Current Liabilities | $1.46B | +5.1% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $1.09B | -14.3% |
| Capital Expenditures | $743.8M | -0.8% |
| Investing Cash Flow | -$800.3M | +15.9% |
| Financing Cash Flow | -$260.4M | -74.5% |
| Free Cash Flow | $345.1M | -33.7% |
| -1.6% |
| EPS (Basic) | $1.44 | -1.4% |
| EPS (Diluted) | $1.43 | -2.1% |
| Long-term Debt |
| $923.4M |
| -13.8% |
| Total Liabilities | $2.76B | -0.5% |
| Stockholders' Equity | $4.15B | +4.7% |